Dept. of Molecular Medicine Aarhus University Hospital Revenue and Competitors

The Dept. of Molecular Medicine (MOMA) houses a close synergy between research, development and clinical activities. The department has a unique position in the form of an interface between Aarhus University (AU), Aarhus University Hospital (AUH) and the Danish National Genome Center (NGC). MOMA holds a laboratory and core center with specialised staff and equipment ready to solve internal and external tasks. We function as a Diagnostic NGS Core Facility which i.a. includes analysis of hereditary and somatic cancer, hereditary heart disease and hereditary endocrine disease. The department has for several years been at the forefront internationally with research within bladder, colorectal and prostate cancer, as well as the development of bioinformatics, which supports data processing both for research and diagnostic purposes. In addition, MOMA conducts research in targeted cancer treatment, kidney cancer and hereditary endocrine disease. Networks and close collaborations have been established around the utilization of genomic data in combination with other data sources, including CONNECT, aiming at improving disease treatment and prevention to benefit the individual patient. MOMA collaborates with leading laboratories worldwide, among these in multiple clinical translational studies. MOMA functions as an interdisciplinary hub with a wide range of expertise and specialties. The department holds large biobanks with samples collected over decades from patients with various clinical diagnose; biobanks which continues to form aunique basis for research of high clinical relevance and international attention. MOMA has been accredited by DANAK/ILAC by the international laboratory standard DS/ENISO 15189:2013 for medical examination - genetics since 2012.